Baker McKenzie advises Cohere on Reliant AI acquisition
Baker McKenzie has advised Cohere on its acquisition of Reliant AI, an AI software company specialising in generative AI solutions and automated data analysis for the biopharma and healthcare industries.
Reliant AI, founded in 2023, operates offices in Montreal and Berlin. Its three co-founders — Karl Moritz Hermann, Richard Schlegel, and Marc G. Bellemare — will join Cohere as part of the deal.
Cohere, founded in 2019 by Aidan Gomez, Ivan Zhang, and Nick Frosst and headquartered in Toronto, plans to integrate Reliant AI’s technology into its product North for Pharma — an agentic AI system designed for biopharma teams working in research and development, clinical development, and scientific analytics.
The Baker McKenzie team
Baker McKenzie advised Cohere with a cross-border team spanning multiple practice areas and offices. The corporate/M&A workstream was led by partner Tino Marz (Munich, pictured) and partner Usman Sheikh (Toronto), supported by associate Erik Kuhn (Munich).
Intellectual property matters were handled by partner Patrick Wilkening (Düsseldorf) and associate Anela Winzig (Frankfurt). On regulatory issues, the team included partner Katharina Weiner (Düsseldorf), counsel Andreas Schulz (Berlin), and associate Stefanie Zenzen (Düsseldorf).
Employment was covered by partner Christian Koops (Munich), counsel Ludmilla Maurer (Frankfurt), and associate Johannes Seeberg-Elverfeldt (Munich). Real estate advice was provided by partner Daniel Bork (Düsseldorf) and associate Moritz Jander (Düsseldorf). Data privacy and tech regulation were handled by partner Florian Tannen (Munich) and associate David Oberhuber (Munich), while tax matters were managed by partner Thomas Gierath (Munich).
